Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sunray3's Profile
Displaying 1-50 of 187 result(s).
CYDY CytoDyn Inc
10/23/2025 11:52:55 AM
Oh crap, awful news, his poor famil (1)
CYDY CytoDyn Inc
10/22/2025 3:17:56 PM
Hey, Respert. "I think it's fair to (11)
CYDY CytoDyn Inc
10/02/2025 7:03:20 PM
All good points..In fairness though (3)
CYDY CytoDyn Inc
10/02/2025 1:54:34 PM
I'm in a similar situation trying t (11)
CYDY CytoDyn Inc
09/06/2025 1:42:07 PM
Now that speaks volumes. Good doc, (4)
CYDY CytoDyn Inc
07/28/2025 7:32:47 PM
I'm sure you're right, there are go
CYDY CytoDyn Inc
07/28/2025 12:02:02 PM
If so (not doubting you) then not h (8)
CYDY CytoDyn Inc
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's sta (7)
CYDY CytoDyn Inc
07/25/2025 2:10:19 PM
Can some kind soul who remembers th (1)
CYDY CytoDyn Inc
07/24/2025 1:58:43 PM
Well said. Free leronlimab! (2)
CYDY CytoDyn Inc
07/23/2025 1:12:31 PM
Oh, I'm sure as I suspect you are t (7)
CYDY CytoDyn Inc
07/23/2025 12:07:51 PM
Now mind you, I don't pretend to kn (3)
CYDY CytoDyn Inc
07/23/2025 11:11:08 AM
Definitely BS, you're right...the M (7)
CYDY CytoDyn Inc
07/22/2025 10:36:07 AM
Well, I must admit that's a compell (11)
CYDY CytoDyn Inc
07/22/2025 9:05:38 AM
Agree, and as you say the acquirer (11)
CYDY CytoDyn Inc
07/03/2025 8:50:48 AM
Ah, good point. Thanks, I agree.
CYDY CytoDyn Inc
07/03/2025 1:08:38 AM
The question for me is does that la (4)
CYDY CytoDyn Inc
06/30/2025 2:48:01 PM
The chart price action has been int (9)
CYDY CytoDyn Inc
06/30/2025 1:09:38 PM
The ORR for TAS-102 and bevacizumab (4)
CYDY CytoDyn Inc
06/27/2025 1:52:44 PM
As I understand it and I've checked (9)
CYDY CytoDyn Inc
06/25/2025 11:11:13 AM
And yet here the Gates foundation i
CYDY CytoDyn Inc
06/24/2025 11:37:56 AM
Syneos as a clinical operations par (5)
CYDY CytoDyn Inc
06/23/2025 7:40:36 PM
Maybe. I agree with you about the m (2)
CYDY CytoDyn Inc
06/23/2025 1:48:54 PM
As per our previous conversation, w (2)
CYDY CytoDyn Inc
06/23/2025 11:58:40 AM
Just looked into it further, that w (1)
CYDY CytoDyn Inc
06/23/2025 10:58:00 AM
No, I think he's just congratulatin (1)
CYDY CytoDyn Inc
06/22/2025 3:25:09 PM
Heavens, I don't recall accusing an (4)
CYDY CytoDyn Inc
06/21/2025 11:31:19 AM
And way cheaper, you can be sure.
CYDY CytoDyn Inc
06/19/2025 4:10:48 PM
I'm no cardiologist, but I think th (3)
CYDY CytoDyn Inc
06/19/2025 11:22:48 AM
Glad you asked, some sources were s (2)
CYDY CytoDyn Inc
06/19/2025 1:05:54 AM
Yes, Dr Welch has many millions of (6)
CYDY CytoDyn Inc
06/17/2025 6:51:40 PM
Here's the link to the chart from m (2)
CYDY CytoDyn Inc
06/17/2025 6:32:13 PM
I can understand your thoughtful ob (2)
CYDY CytoDyn Inc
06/17/2025 12:43:00 PM
Yes to the first, no to the second. (7)
CYDY CytoDyn Inc
06/16/2025 9:58:58 AM
Pretty much, except that the two Me (1)
CYDY CytoDyn Inc
06/16/2025 2:33:07 AM
And let's not forget the PD-L1 bloc (7)
CYDY CytoDyn Inc
06/11/2025 3:41:44 PM
Nice reply, thanks. I agree general (9)
CYDY CytoDyn Inc
06/10/2025 2:00:30 PM
OK mods, this is that last one, I p (5)
CYDY CytoDyn Inc
06/10/2025 1:07:07 PM
I asked ChatGPT to analyze the leve (8)
CYDY CytoDyn Inc
06/10/2025 11:18:18 AM
Yeah, I guess that would be my poin (3)
CYDY CytoDyn Inc
06/10/2025 10:50:09 AM
And regarding the regulatory treatm (3)
CYDY CytoDyn Inc
06/10/2025 10:11:00 AM
I did some further research utilizi (4)
CYDY CytoDyn Inc
06/08/2025 10:52:28 AM
I agree, actually, and there's no w (7)
CYDY CytoDyn Inc
05/27/2025 10:39:42 AM
Touche, KC, that was hilarious, poi (4)
CYDY CytoDyn Inc
05/27/2025 9:29:27 AM
I agree. I use ChatGPT for research (3)
CYDY CytoDyn Inc
05/26/2025 7:34:40 PM
Interesting thought! In athe same v (12)
CYDY CytoDyn Inc
05/22/2025 1:51:52 PM
I understand what you're saying and (2)
CYDY CytoDyn Inc
05/19/2025 11:52:08 AM
I'm with you there, Max (ViiV/GSK) (2)
CYDY CytoDyn Inc
05/19/2025 11:10:11 AM
And if they wanted, Merck could rea (2)
CYDY CytoDyn Inc
05/18/2025 4:57:45 PM
Not being contrary here, but I just (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Pulsar Helium's Exciting Move into Michigan's Exploration Market
  • Ford Faces Tariff Challenges While Competing with Chinese EVs
  • US Stock Market Experiences Record Gains Amid Easing Concerns
  • Carter's Earnings Forecast: Analysts Weigh In on Performance
  • Dr. Mandeep Dhalla Joins DentScribe.ai as Strategic Advisor
  • Exploring the Growth of Wind Turbine Pitch & Yaw Drive Market
  • Exosens Reports Strong Performance in 9M 2025 with Growth Strategy
  • Infortar's Recent Share Buyback Strategy Unveiled
  • Corbion's Share Buyback Program Update and Insights
  • Pulsar Helium's Strategic Move to Expand into Michigan's Market
  • Javier Milei's Victory: A New Era for Bitcoin Advocates
  • Stocks to Keep an Eye on This Week: Insights and Analysis
  • Al Madinah's Strategic Role in Saudi Arabia's Vision 2030 Ambitions
  • Vyonix Unveils Revolutionary Laptops at Industry Conference
  • Unified Wealth Reaches Milestone: $100 Million in Assets
  • Mowi ASA's Q3 2025 Results: Webcast and Insights Overview
  • Microsoft Faces Legal Scrutiny Over Alleged AI Pricing Issues
  • Jim Cramer's Insight on Elon Musk's Ambitious Compensation Plan
  • I-Tech Advocates for Change in EU Shipping Regulations
  • Examining the Challenges in EU Shipping Regulations Amid Climate Goals
  • Legal Action Filed After Tragic 605 Freeway Crash Incident
  • Senator Critiques Corporate Funding for Trump's Ballroom Project
  • CreatorWeek Macao 2025: A Celebration of Global Creativity
  • Dogecoin's Remarkable Rally: What's Driving Its Surge?
  • Celebrating Cultural Exchange: Silk Road Week's Brazil Finale
  • GenieAI's Allo Platform Now Available for All Clients Globally
  • Discover CreatorWeek 2025: A Hub for Global Innovation and Artistry
  • Discover the Latest Motorola Q15 Mesh Router and Features
  • MoneyHero Unveils Project Odyssey for AI-Driven Success
  • Silk Road Week Ends in Brazil, Celebrating Cultural Connections
  • Ro Khanna Proposes Ban on Cryptocurrency for President's Family
  • Health Canada's Approval Marks Milestone for Leqembi Treatment
  • Health Canada Approves Leqembi for Early Alzheimer's Treatment
  • CSL’s Award-Winning Facility: Leading Pharma Innovation
  • CSL Broadmeadows Facility: A Benchmark in Biopharma Innovation
  • HD Hyundai Explores Innovative Shipbuilding Solutions at APEC
  • UGREEN Launches Innovative NASync DXP2800 in Walmart Stores
  • Transforming Recruitment: Meet Savos, Your AI Hiring Partner
  • UniPin's Strategic Moves: Game Industry Expansion in Asia
  • Apple Maps Ad Strategy: Innovations and Consumer Response
  • Cryptocurrency Gains Ground Amid Trade Deal Optimism
  • How Takaichi's Strategy with Trump Could Boost Ford Sales
  • Langjiu's Italian Adventure: Bridging Cultures with Baijiu
  • Hong Kong's Role in Shaping Greater Bay Area Growth and Innovation
  • Explore the Vibrant Yangtze River Cultural Festival Experience
  • NetDragon Teams Up with Open University Malaysia for Innovative AI Education
  • NetDragon Partners with OUM to Innovate in AI Education
  • Antengene Unveils Groundbreaking Preclinical Insights on ATG-201
  • Insights into the Trucking Industry's Major Challenges
  • Genenta Science Secures $15 Million in Direct Offering for Shares
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site